Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 3.83 Delayed Data As of Dec 08 |  -0.18 / -4.49%Today’s Change | 2.33 Today|||52-Week Range 8.70 | +39.27% Year-to-Date |
Latest VRCA News | Press Releases
No recent news for Verrica Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.01 |
| Today’s open | 4.04 |
| Day’s range | 3.75 - 4.04 |
| Volume | 90,459 |
| Average volume (3 months) | 191,317 |
| Market cap | $163.6M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +44.74% |
| Earnings growth (this year) | -44.02% |
| Earnings growth (next 5 years) | -20.18% |
| Revenue growth (last year) | -24.73% |
| P/E ratio | NM |
| Price/Sales | 10.40 |
| Price/Book | 3.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OMEROmeros Corp | -0.02 | -0.58% |
| PDSBPDS Biotechnology Co... | +0.03 | +0.59% |
| PRQRProQR Therapeutics N... | -0.04 | -1.96% |
| --Ecogreen Internation... | 0.00 | 0.00% |
Data as of 4:00pm ET, 12/08/2023
Financials
| Next reporting date | March 6, 2024 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $9.0M |
| Annual profit (last year) | -$24.5M |
| Net profit margin | -271.11% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters West Chester, Pennsylvania |
Forecasts
